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Abstract
Background—Innate immune gene expression is regulated in part through high mobility group
box 1(HMGB1), an endogenous proinflammatory cytokine, that activates multiple members of the
interleukin-1/Toll-like receptor (IL-1/TLR) family associated with danger signaling. We
investigated expression of HMGB1, TLR2, TLR3 and TLR4 in chronic ethanol treated mouse
brain, post-mortem human alcoholic brain, and rat brain slice culture to test the hypothesis that
neuroimmune activation in alcoholic brain involves ethanol activation of HMGB1/TLR danger
signaling.
Methods—Protein levels were assessed using Western blot, ELISA, immunohistochemical
immunoreactivity (+IR), and mRNA levels were measured by real time PCR in ethanol-treated
mice (5 g/kg/day, i.g., 10 days + 24 hr), rat brain slice culture, and post-mortem human alcoholic
brain.
Results—Ethanol treatment of mice increased brain mRNA and +IR protein expression of
HMGB1, TLR2, TLR3, and TLR4. Post-mortem human alcoholic brain also showed increased
HMGB1, TLR2, TLR3, and TLR4+IR cells that correlated with lifetime alcohol consumption as
well as each other. Ethanol treatment of brain slice culture released HMGB1 into the media and
induced the proinflammatory cytokine, IL-1β. Neutralizing antibodies to HMGB1 and small
inhibitory mRNA to HMGB1 or TLR4 blunted ethanol induction of IL-1β.
Conclusions—Ethanol-induced HMGB1/TLR signaling contributes to induction of the
proinflammatory cytokine, IL-1β. Increased expression of HMGB1, TLR2, TLR3, and TLR4 in
alcoholic brain and in mice treated with ethanol suggests that chronic alcohol-induced brain
neuroimmune activation occurs through HMGB1/TLR signaling.
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Neuroinflammation is implicated in the etiology of many brain diseases. Recent discoveries
indicate that endogenous danger-associated molecular pattern agonists and Toll-like
receptors (TLRs) contribute to neuroinflammation [1–3]. High-mobility group box 1
(HMGB1) is an endogenous danger signaling cytokine that acts on multiple interleukin-1/
Toll-like receptors (IL-1/TLRs) [2, 4, 5]. The family of IL-1/TLRs signal through kinases
that activate the proinflammatory transcription factor nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) increasing expression of cytokines, oxidases, and
other genes associated with innate immune responses [6]. Although there are multiple TLRs
in the brains of mice and humans, TLR2, TLR3, and TLR4 are the most commonly studied.
HMGB1/TLR danger signaling is associated with persistent chronic inflammatory diseases
[7], and our studies find that once induced, neuroimmune activation in brain persists for long
periods. For example, ethanol [8] and endotoxin [9] treatment of mice increases
proinflammatory gene expression in brain that persist for weeks to months after treatment.
Thus, we hypothesized that HMGB1/TLR danger signaling might contribute to ethanol-
induced neuroinflammation and the neurobiology of alcoholism.
We have previously found that ethanol increases expression of brain proinflammatory genes
through activation of the transcription factor, NF-κB [6, 10]. Chronic ethanol-induced
expression of brain proinflammatory cytokines and oxidases are linked to neurodegeneration
[8, 11] and inhibition of neurogenesis [12]. In post-mortem human alcoholic brain we found
increased expression of the proinflammatory chemokine, monocyte chemoattractant protein,
MCP1 and markers of microglial activation [13], and increased expression of IL-1β and
inflammasome proteins [14] as well as increased expression of proinflammatory NADPH
oxidase [15], indicating significant neuroimmune activation in alcoholic human brain.
Further, transgenic mice lacking TLR4 are protected against ethanol-induced
proinflammatory gene induction, glial activation, and neurotoxicity [16]. HMGB1/TLR
danger signals may also impact responses to ethanol since knockdown of amygdala TLR4
with small inhibitory RNA (siRNA) blunts ethanol-dependent rat operant responding for
ethanol [17] and acute behavioral responses to ethanol are altered in transgenic mice lacking
TLR2 and/or TLR4 [18]. Studies in mice have found that neuroimmune activation increases
ethanol drinking [19], whereas transgenic mice lacking innate immune genes drink less than
their wild-type controls [20]. These studies suggest that the actions of ethanol in brain
include neuroimmune activation consistent with danger signaling through TLR4 and perhaps
other TLRs. Thus, alcoholic human brain shows neuroimmune activation and ethanol-
induced neuroimmune activation is linked to drinking behavior, alcohol responses, TLR
upregulation, and neurodegeneration.
We report here that ethanol treatment of mice or rat brain sections in vitro increase
expression of HMGB1/TLRs. Post-mortem human alcoholic brain was found to have
significantly more HMGB1, TLR2, TLR3, and TLR4 which correlated with lifetime alcohol
consumption. Furthermore, ethanol was found to release HMGB1 from brain slice culture
activating proinflammatory IL-β synthesis through TLR4. These findings support the
hypothesis that ethanol activation of HMGB1/TLR danger signaling contributes to
neuroimmune activation in alcoholic brain and to the neurobiology of alcoholism.
Methods and Materials
Animals
Eight-week old male (20–22 g) C57BL/6 mice were purchased from Jackson Laboratories
(Bar Harbor, Maine). After at least 1 week of acclimation to the animal colony, mice were
divided into control and ethanol groups. Mice were treated with water (control) or ethanol (5
Crews et al. Page 2













g/kg, i.g., 25% ethanol w/v), with volumes matched, daily for 10 days and sacrificed 24 hr
later. The average blood ethanol concentration (BEC) at 1 hr after the first ethanol treatment
and the last ethanol treatment was 291 ± 16 mg/dl (w/v, n=10) and 301 ± 19 mg/dl (w/v,
n=10), respectively. The BEC is high modeling alcoholic binge drinking [21]. Brain slice
culture was prepared from P7 pups from timed pregnant Sprague-Dawley rats.
All protocols and procedures in this study were approved by the Institutional Animal Care
and Use Committee and were conducted in accordance with the National Institute of Health
regulations for the care and use of animals in research. Details on reagents and reagents
sources and equipment are listed within the supplemental methods and materials section.
Brain Slice Culture
Organotypic hippocampal-entorhinal cortex (HEC) brain slice culture was prepared from P7
Sprague-Dawley rat pups as described previously [6, 22]. After 10 days in culture, slices
were used for experimental treatments as described below.
Human tissue
Human post-mortem brain tissue was obtained from the New South Wales Tissue Resource
Center in Australia [ethics committee approval number: X11-0107]. Paraffin sections of
orbitofrontal cortex (OFC) were used in this study. The detailed patients’ medical history is
presented in Table1. Human alcoholic patients, which averaged over 10 drinks per day with
lifetime consumption of over 500 kg of alcohol, were compared to moderate drinkers who
averaged less than 1 drink per day with lifetime consumption of less than 100 kg of alcohol.
Total lifetime alcohol consumption provides an index of alcoholic neurodegeneration [23,
24], whereas there is no relationship among moderate drinkers [24, 25]. Only individuals
with alcohol dependence not complicated by liver cirrhosis or nutritional deficiencies were
included in this study. The most common cause of death was cardiovascular disease for both
groups. Post-mortem interval (PMI) causes of death and alcohol consumption are
documented. All psychiatric and alcohol use disorder diagnoses were confirmed using the
Diagnostic Instrument for Brain Studies which complies with the Diagnostic Statistical
Manual of Mental Disorders and has demonstrated reliability [26].
Real-time PCR analysis
Total RNA was extracted from mouse brain or rat brain slice culture. Real-time PCR was
performed as described previously [27] and is in supplemental methods and materials
section. The primer sequences used in this study were as follows:
Immunohistochemistry—Mouse brains were fixed with 4% paraformaldehyde in
phosphate buffered saline (PBS) and processed for immunostaining as described previously
[27]. Table 3 describes the antibodies used for immunostaining of TLR2, TLR3, TLR4 and
HMGB1. Immunolabeling was visualized by using nickel-enhanced 3,3′-diaminobenzidine
(DAB).
Stereological cell counts—Immunoreactive (+IR) cells were quantified using unbiased
stereological cell counts in six random regions of interest from each brain sample and were
counted at 40X. Cell density (Nv) was determined following the optical dissector method
[28, 29], as described previously [8, 27]. More details on the cell counting methods are
described in the supplement.
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At the conclusion of ethanol treatment, HEC slices were removed for real-time PCR or
immunohistochemistry and culture media were used for ELISA detection of released
HMGB1. HMGB1 ELISA was performed according to the manufacturer’s protocol of
ELISA kits (IBL, Germany).
TLR4 or HMGB1 knockdown with siRNA
Rat TLR4 or HMGB1 siRNA (Ambion, Grand Island, NY) was used to knockdown TLR4
or HMGB1 expression. Preparation of transfection reagents and transfection was performed
as previously described [14]. Briefly, the transfection mixture was added to serum-free N2
medium at a final concentration of 20 nM siRNA + 6 μl Lipofectamine 2000 to a total
volume of 1.2 ml (500 μl on top of slices and 700 μl at bottom of the culture). Vehicle
controls were treated with the same N2 medium containing negative control siRNA
(Ambion, Grand Island, NY). After 24 hr transfection, siRNA-containing medium was
replaced with regular serum-free N2-supplemented medium and the slices were cultured for
4 days in the absence or presence of ethanol (100 mM). At the end of experiments, the slices
were removed for real-time PCR analysis.
Western blotting
For human Western blots, 30 mg of frozen OFC tissue was homogenized in 0.2 ml RIPA
lysis buffer with protease inhibitor (1ml/10ml buffer) and centrifuged at 14000 rpm at 4°C
for 1 hr. Protein in the supernatant was measured using Pierce BCA protein assay kit
(Thermo Scientific, Rockford, IL) and 25 μg of protein from each denatured sample was
subjected to SDS-PAGE on Bio-Rad Precast polyacrylamide mini-gel (4–15%) and blotted
onto immunoblot PVDF membrane. Antibodies were used to identify TLR2, TLR3, TLR4,
and HMGB1 bands (table 3). Bands were scanned with Odyssey Infrared imager from LI-
COR Bioscience (Lincoln, NE). Band intensity was quantitated using Bioquant Imaging
software and normalized to β-actin band intensity. To support antibody specificity, TLR2,
TLR3, TLR4 and HMGB1 antibody preabsorption was performed using 0.5 μg/ml of the
corresponding blocking peptides.
Western blot analysis of HEC slices used lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 10
mM KCl, pH 7.9) plus protease inhibitor cocktail (Sigma) for 15 min and then disrupted
with sonication (3 time, 2 min apart on ice). After centrifugation, the supernatant were
collected, and protein determined using a Bio-Rad Bradford reagent kit. For Western
blotting, an equal amount of protein (50 μg) or culture medium (40 μl) was mixed with 10/
μl 5× loading buffer, and separated using a 4–15% Tris mini-gel (Bio-Rad) and transferred
onto PVDF membrane. After blocking with LI-COR blocking buffer overnight, the
membrane was probed with anti-HMGB1 antibody (1:400, Abcam) at 4°C overnight. After
washing, membrane was incubated with second antibodies coupled with fluorescence from
LI-COR Bioscience (Lincoln, NE).
Statistical analysis
The data are expressed as mean ± SEM and statistical significance was assessed with a
ANOVA followed by Bonferroni’s t-test using the StatView program (Abacus Concepts,
Berkeley, CA). A value of p < 0.05 was considered statistically significant. The association
between HMGB1, TLR, and lifetime alcohol consumption was analyzed with the Pearson
product-moment correlation coefficient (Pearson correlations (r)) to determine meaningful
relationships.
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Increased expression of danger signaling HMGB1 and TLR2, TLR3, and TLR4 in ethanol-
treated mouse brain
To investigate the effects of chronic binge-like ethanol treatment on danger signal
expression, C57BL/6 mice were treated for 10 days with a binge drinking dose of ethanol.
Ethanol treatment of mice increased brain TLR2 mRNA 241±26% (p<0.05), TLR3 mRNA
167±17% (p<0.05), and TLR4 mRNA 233±29% (p<0.01) (Figure 1). To determine protein
expression in orbital frontal cortex (OFC) and entorhinal cortex (ENT), we determined
immunoreactivity (+IR) for each of these proteins. The controls in both OFC (Figure 1C)
and ENT (images not shown) showed low levels of diffuse staining of small punctate spots
with a few cellular silhouettes for all three TLRs. Ethanol treatment increased staining,
particularly cellular staining (Figure 1C). In OFC, ethanol treatment increased TLR2+IR
cells 176±10% (p<0.01), TLR3+IR cells 151±10% (p<0.01) and TLR4+IR cells 174±12%
(p<0.01). In ENT, ethanol treatment increased TLR2+IR cells 165±9% (p<0.01), increased
TLR3+IR cells 183±9% (p<0.01), and increased TLR4+IR cells 221±13% (p<0.01).
Increases in TLR2, TLR3, and TLR4 mRNA, and cell staining +IR are consistent with
ethanol treatment of mice inducing expression of all three TLRs in cortex.
HMGB1 is a commonly expressed cellular protein [4]. In mice treated with chronic ethanol,
brain HMGB1 mRNA increased to 219±20% (p<0.01) of control brain mRNA (Figure 3A).
Immunohistochemical staining of protein +IR found OFC increased 181±9% (p<0.01) and
ENT 195±5% (p<0.01) (Figure 3B). In controls, there were at least two types of cellular
staining: (1) large cells with strong membrane staining silhouettes, and (2) smaller cells with
more homogenous staining. Both forms of cellular staining appeared to increase with
ethanol treatment. Thus, chronic ethanol treatment of mice increases brain HMGB1 mRNA
and the number of HMGB1+IR cells in OFC and ENT. These findings suggest that chronic
ethanol treatment of mice increases danger signaling agonist HMGB1 as well as danger
signaling receptors TLR2, TLR3, and TLR4 in cortex.
Increased expression of danger signaling HMGB1 and TLR2, TLR3, and TLR4 in post-
mortem human alcoholic brain
In previous studies, we found that post-mortem human alcoholic brain has increased
expression of the proinflammatory chemokine MCP1 and microglial markers [13], increased
expression of IL-1β and inflammasome proteins [14] and increased expression of
proinflammatory NADPH oxidase (NOX) [15]. We studied post-mortem human OFC to
determine if HMGB1/TLR danger signaling molecules were increased in alcoholic brain
(Table 1, Figure 4 and 5). Moderate drinking controls showed little TLR2+IR staining.
TLR3+IR controls showed a few cells and stained processes, but overall low levels of
staining. TLR4+IR in controls showed large and small cellular silhouettes (images not
shown). Alcoholic brains showed increased TLR2+IR cells 208±15% (p<0.01), TLR3+IR
cells 259±18% (p<0.01), and TLR4+IR cells 356±73% (p<0.01), compared to moderate
drinking controls. Western blot analysis of protein expression levels also indicated increased
levels of TLR2 (147±14%, p<0.05), TLR3 (180±27, p<0.05) and TLR4 (184±24%, p<0.01)
(Figure 4). Thus, both methods of quantification found significant increases in post-mortem
human alcoholic OFC. Similar to that found in ethanol-treated mouse brain, post-mortem
alcoholic brain OFC showed increased expression of HMGB1+IR cells (213±21%, p<0.05,
Figure 5) and Western blot HMGB1 protein (151±18%, p<0.01, Figure 5). Surprisingly,
most labeled cells appeared to have neuronal morphology promoting further analysis in
alcoholic brain where staining was prominent. Double confocal immunohistochemistry
using NeuN to identify neuronal cells indicated that NeuN+IR colocalization with 90±2.4%
of TLR2+IR cells, 89.4±1.8% of TLR3+IR cells, 80.6±1.5% of TLR4+IR cells, and 82.7 ±
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4.3% of HMGB1+IR cells (Supplemental Figure S1). Increased expression of the cytokine
HMGB1, as well as TLR2, TLR3, and TLR4, suggest increased HMGB1/TLR signaling in
alcoholic brain.
Our findings of increased HMGB1, TLR2, TLR3, and TLR4 in chronic ethanol-treated
mouse brain as well as human alcoholic brain prompted a comparison of human lifetime
alcohol consumption with expression of HMGB1/TLR danger signaling molecules.
HMGB1, TLR2, TLR3, and TLR4 all showed significant correlations with lifetime alcohol
consumption (Table 4, Figure 6). Moderate drinking control subjects consumed much less
lifetime alcohol with the heaviest drinking control consuming approximately 100 kg of
alcohol. Alcoholics in our study consumed between 500 and 5,000 kg of alcohol providing a
broad range of consumption that shows a progressive increase in HMGB1 expression with
increased lifetime drinking (Figure 6). HMGB1 and TLR3 showed the strongest correlations
with lifetime alcohol consumption, although TLR2 and TLR4 were significantly correlated.
The correlation of HMGB1 as well as TLR2, TLR3, and TLR4 with lifetime ethanol
consumption is consistent with ethanol induction of these proteins in brain.
HMGB1 and TLRs are required for ethanol induction of proinflammatory interleukin-1β
(IL-1β)
To determine if the increased in expression of HMGB1/TLR danger signaling proteins
actually increased neuroimmune gene expression, we assessed ethanol effects on danger
signaling in slice culture. We have previously found that ethanol treatment of brain slice
culture increases NF-κB-DNA binding and transcription of multiple neuroimmune
cytokines, oxidases, and proteases [11, 30]. We first determined whether ethanol treatment
induced HMGB1 in rat brain slice cultures. Ethanol treatment increased HMGB1 mRNA
about 4.5-fold (Figure 7). We had limited hippocampal sections from human post-mortem
brain, but staining of individual samples from moderate drinking controls and alcoholics
suggest similar increases in HMGB1+IR in hippocampus (Figure 7) to those found in cortex
(Figure 5). Ethanol-treated rat brain slice culture showed that expression of HMGB1
colocalizes with neurons (NeuN+IR) using confocal microscopy (i.e. red-HMGB1 and
green-NeuN coincide forming yellow, Figure 7). Thus, ethanol treatment of slice culture
increases HMGB1 mRNA that histochemically appears to be in neurons.
Our previous studies found that ethanol-induced neuroimmune activation is amplified by
signals that converge upon NF-κB transcription of proinflammatory genes that form positive
loops of activation [6] increasing transcription of multiple cytokines, cytokine receptors and
TLRs, oxidases and proteases [8, 11, 15, 30]. To investigate the role of HMGB1/TLR
signaling, we followed IL-1β which we have previously found to be induced by ethanol in
brain slice culture and in mice treated with ethanol [11, 14]. Ethanol increased HMGB1
protein within the brain slices as well as the media as determined using Western blots and
ELISA (Figure 8). Ethanol treatment of brain slice culture also increased expression of
IL-1β mRNA, similar to previous studies [11]. Interestingly, ethanol increased IL-1β
expression was blocked by the addition of a neutralizing HMGB1 antibody (Figure 8).
Neutralizing antibody binds HMGB1 preventing its interaction with receptors suggesting
that ethanol released HMGB1 contributes to ethanol induction of IL-1β. We used small
inhibitory mRNA to knockdown expression of HMGB1 or TLR4, a key TLR in HMGB1
proinflammatory responses. We found that knockdown of HMGB1 or TLR4 blocked
ethanol induction of IL-1β. These findings suggest that ethanol releases HMGB1 that
stimulates TLR4 leading to induction of IL-1β.
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Coincident induction of danger signaling molecules by ethanol
Our previous studies have found that ethanol induces brain neuroinflammatory responses
through increased NF-κB transcription of proinflammatory genes including TLRs, cytokines
such as TNFα, IL-6, IL-1β, and the chemokine MCP1, as well as oxidases COX and NOX,
and other innate immune genes that contribute to persistence and amplification of brain
neuroimmune responses [6, 10]. The finding that all of the HMGB1/TLR danger signaling
molecules investigated in this study were increased by ethanol and correlated with lifetime
ethanol consumption prompted assessment of correlations among the four HMGB1/TLR
danger signaling molecules. Interestingly, HMGB1+IR cells in post-mortem human brain
were correlated with TLR2, TLR3, and TLR4+IR cell expression (r=0.85, p<0.0001; Figure
9) and to each other (Table 4). The correlated increases in HMGB1 expression across all 3
TLRs is consistent with other findings of proinflammatory responses involving overlapping
amplification of signals that contribute to persistent neuroimmune signaling [6]. Our finding
that TLR2, TLR3, and TLR4 all correlate with increased HMGB1 and each other suggest
that all are upregulated together as neuroimmune activation is amplified across cells and
innate immune genes. This is consistent with ethanol exposure increasing neuroimmune
activation through positive loops of innate immune gene induction that amplify multiple
HMGB1/TLR danger signals and other neuroimmune genes in parallel (Figure 10).
Discussion
We report here that chronic ethanol treatment of mice increases HMGB1 mRNA and
cellular expression of protein in OFC (i.e., HMGB1+IR). We also found HMGB1+IR
increased in the human post-mortem OFC. HMGB1 is a common nuclear protein that is
released by active and passive processes and has cytokine-like properties expressed through
activation of IL-1/TLRs that stimulate NF-κB transcription of innate immune genes [2, 4].
Using cultured brain slices, we found that ethanol increased HMGB1 in medium, consistent
with ethanol both inducing and releasing HMGB1. We have previously found that chronic
ethanol treatment increases expression of brain NF-κB proinflammatory target genes
including COX [31], NOX [15], multiple cytokines, proteases, and oxidases [8, 11, 15] as
well as increasing NF-κB-DNA binding in vivo [10] and in brain slice culture [30].
Although HMGB1 can bind to and activate multiple TLRs, signaling is complex due to
neuroimmune amplification within and across cells that release additional HMGB1, other
cytokines, and molecules that contribute to the response [2, 4]. In previous studies, we found
ethanol pretreatment of mice potentiated TLR3 agonist Poly I:C [32] and TLR4 agonist LPS
[8] induced proinflammatory gene induction. Although HMGB1 can activate multiple
receptors and HMGB1 injected into brain causes cognitive deficits through multiple
receptors [33], proinflammatory activation of innate immune cells by HMGB1 requires
TLR4 [34, 35]. Many studies have suggested that brain neuroimmune activation requires
microglia activation through TLR4 [36, 37]. Microglial TLR4 is also critical for activation
of astrocyte proinflammatory responses [38] perhaps due to basal expression of TLR4 on
microglia, but not other brain cells [39]. Ethanol activation of NF-κB proinflammatory
transcription in isolated microglia [40] and mouse brain [16] is dependent upon TLR4. Since
microglia are known to express high basal levels of TLR4 and to rapidly release IL-1β in
response to danger signals [4, 41], it is possible that the pivotal role of TLR4 for ethanol
responses is due to the critical role of TLR4 in HMGB1 microglial activation and the
resulting amplification of responses by astrocytes and neurons (Figure 10). Although
HMGB1 signaling is complex, our findings are consistent with ethanol releasing HMGB1
that activates TLR4 receptors that increase NF-κB transcription of IL-1β and other
proinflammatory genes that lead to neuroimmune activation (Figure 10).
We found increased expression of HMGB1, TLR2, TLR3, and TLR4 in OFC of human
post-mortem alcoholic brain and chronic ethanol-treated mouse brain. Similar to other
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reports, we found low levels of TLR expression in non-diseased human brain [42]. Other
human postmortem studies report low levels of expression in healthy brain and broad brain
regional increases in the expression of multiple TLRs across various brain diseases [42].
Proinflammatory gene induction is linked to neurodegeneration and the brains of transgenic
mice lacking TLRs are protected against brain insults including ethanol [16, 43–45]. For
instance, in models of stroke, mice lacking TLR2 or TLR4 have reduced infarct size and
neuroimmune activation [43, 44], whereas in normal mice stroke models increase brain
TLR2 and TLR4 expression [34, 44] and brain injection of HMGB1 increases infarct size
[34]. Increased HMGB1 expression has been reported in hippocampal tissue from patients
with temporal lobe epilepsy [46]. These studies found that glutamate hyperexcitability
increases release of neuronal HMGB1 that activates TLR4 receptors releasing the
proconvulsant IL-1β, increasing seizure severity, and a long-lasting decrease in seizure
threshold contributing to persistent risk of additional seizures [4, 41, 46]. Chronic alcohol
treatment is also known to reduce seizure threshold, perhaps due to HMGB1/TLR induction.
Similarly, neuroimmune microglial activation is associated with increased spinal cord
hyperexcitability in models of chronic pain [47] that also finds persistent endogenous release
of HMGB1 associated with the hyperexcitability [48]. Chronic ethanol also impacts chronic
pain [49]. We studied human and mouse frontal cortex, the brain region most associated
with alcoholic neurodegeneration [24, 50] and found increased expression of HMGB1/
TLRs. We have previously established ethanol induced neuroimmune activation is a key
component of neurodegeneration associated with ethanol exposure [6, 12]. Our studies of
post-mortem human alcoholic brain find increased microglial markers and proinflammatory
MCP-1 in multiple brain regions [13], increased IL-1β and inflammasome proteins [14], and
increased NADPH oxidase gp91, an innate immune oxidase linked to neurodegeneration
[15]. In addition to neurodegeneration, HMGB1/TLR signaling links neuroimmune
activation to components of addiction [6, 51]. Genetic studies have identified NF-κB and
proinflammatory genes as contributing to a genetic preference for drinking alcohol [52] and
human genetic studies have identified alleles of NF-κB1, a gene encoding a subunit of NF-
κB, are associated with increased risk of alcoholism [53] and other studies have linked
innate immune genes to alcoholism [54]. Transgenic animals lacking innate immune genes
show reduced alcohol drinking [6, 19] and altered acute ethanol motor and sedative
responses [18]. Further, endotoxin produces persistent neuroimmune activation [9] and
increased ethanol drinking in mice [1, 19]. Lever pressing for ethanol by ethanol-dependent
rats is reduced by viral vector siRNA knockdown of TLR4 in brain [3, 17] and naltrexone, a
drug that reduces alcohol drinking in rodents and is used to treat alcoholism, that also blunts
ethanol induced neuroimmune activation [15], likely through a recently discovered
antagonist action on TLR4 receptors [55]. These findings suggest increased HMGB1/TLR
signaling contributes to alcoholic pathology.
We found that HMGB1+IR cells in OFC correlated with lifetime alcohol consumption and
with TLR2, TLR3, and TLR4+IR cells. Alcoholic subject’s lifetime alcohol consumption
varied by over 10 fold and was far greater than the highest control. The correlation of
HMGB1/TLR expression with lifetime alcohol consumption is consistent with alcohol
induction of persistent neuroimmune activation. Neuroimmune activation by ethanol [8] or
endotoxin [9] persists for long periods. HMGB1 and the TLRs all correlated with each other
consistent with proinflammatory amplification of neuroimmune signals through positive
loops of activation (Figure 10). Although TLR4 is critical for initiation of microglial
activation, amplification through positive loops likely involves multiple proinflammatory
cytokines and HMGB1/TLR danger signals that are upregulated in multiple brain cell types
as neuroimmune activation spreads across the brain. Neuroimmune activation is associated
with drug reward and addiction [6, 51, 56], depression-negative affect [57] and
neurodegeneration [45, 58] consistent with HMGB1/TLR signaling contributing to the
alcoholic pathologies.
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Figure 1. Chronic ethanol treatment of C57BL/6 mice increases mRNA and protein expression
(+IR) of TLR2, TLR3, and TLR4
(A) Levels of brain TLR2, TLR3, and TLR4 mRNA were measured by real-time PCR as
described in the methods. Ethanol treatment significantly increased brain mRNA for TLR2,
TLR3, and TLR4. (B) Immunoreactive (+IR) cells were quantified using unbiased
stereological cell counts as described in the methods and supplement. TLR2, TLR3, and
TLR4+IR cells were counted in mouse orbital frontal cortex (OFC). Ethanol significantly
increased the number of TLR2, TLR3, and TLR4+IR positive cells. (C) Representative
images of immunohistochemical staining for TLR2, TLR3 and TLR4 in the OFC region of
control and ethanol-treated mice. Note staining for TLR in ethanol treated animal labels
membranes of fairly large cells as well as smaller cells. * p < 0.05, ** p < 0.01, compared
with water control group. Scale bar=50μm.
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Figure 2. Chronic ethanol treatment of C57BL/6 mice (5 g/kg, i.g., daily for 10 days) increases
TLR2, TLR3, and TLR4+IR cells in entorhinal cortex
Immunoreactive (+IR) cells were quantified in the entorhinal cortex (ENT) using unbiased
stereological cell counts as described in the methods and supplement. Ethanol increased the
number of TLR2, TLR3 and TLR4 +IR cells. ** p < 0.01, compared with water control
group.
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Figure 3. Ethanol increases HMGB1 expression in mouse brain
Chronic ethanol treatment of C57BL/6 mice (5 g/kg, i.g., daily for 10 days) increased
mRNA and protein expression (+IR) of brain HMGB1. (A) HMGB1 gene expression was
measured by real-time PCR. Chronic ethanol increased brain HMGB1 mRNA by
approximately 2-fold. (B) Quantitative evaluation of HMGB1+IR in the OFC and ENT of
control and ethanol-treated mice. Immunoreactive cells were quantified using unbiased
stereological cell counts as described in the methods and supplement. The number of
HMGB1+IR cells was increased 1.8 fold in OFC and 2-fold in ENT. (C) Representative
images of immunostaining for HMGB1 in the OFC and ENT regions of water and ethanol-
treated mice. ** p < 0.01, compared with water control group. Scale bar=50μm.
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Figure 4. Increased expression of TLR2, TLR3, and TLR4 in post-mortem human alcoholic
brain
See Table 1 for human subject details. (A) Quantification of TLR2, TLR3, and TLR4+IR
cells. Immunoreactive (+IR) cells were quantified using unbiased stereological cell counts as
described in the methods and supplement. The OFC of human post-mortem alcoholic brain
had significantly more TLR2, TLR3, and TLR4 + IR cells, compared to the OFC of human
moderate drinking controls (n=10 per group) (B) Quantification of Western blot analysis
relative to β-actin. (n=8 per group). Although IHC and Western blots are from different
subregions of OFC and different methodologies, Pearson’s correlation of +IR vs. Western
blot intensity was significant across subjects for TLR4 (r=0.61; p<0.05) and TLR3 (r=0.56,
p<0.05), but TLR2 did not reach significance. (C) Images of Western blot. C is control and
A is alcoholic with the # being individual patient. (C4+P = control patient 4 with peptide
preabsorption; A4+P = alcoholic patient 4 with peptide preabsorption) Note that peptide
preabsorption blocks antibody supporting specificity of binding. Alcoholic patients have
more TLR2, TLR3, and TLR4 protein expression.
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Figure 5. HMGB1 expression is increased in the post-mortem human alcoholic brain
(A) Quantification of HMGB1 immunoreactivity. Immunoreactive (+IR) cells were
quantified using unbiased stereological cell counts as described in the methods and
supplement. The number of HMGB1+IR cells was significantly increased in alcoholic brain
(n=10), compared to human moderate drinking controls. (B) Quantification of Western blot
analysis relative to β-actin. (n=8 per group). * p < 0.05,** p < 0.01, relative to moderate
drinking controls. (C) Images of Western blot. C is control and A is alcoholic with the #
being individual patient. (C4+P = control patient 4 with peptide preabsorption; A4+P =
alcoholic patient 4 with peptide preabsorption) Note that peptide preabsorption blocks
antibody supporting specificity of binding. Alcoholic patients have more HMGB1 protein
expression.
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Figure 6. HMGB1+IR cells in OFC correlate with lifetime alcohol consumption
Shown are individual HMGB1+IR cell counts vs. lifetime alcohol consumption. Note that
control subjects are clustered along the y axis due to low lifetime alcohol consumption
values and similar levels of HMGB1+IR. Alcoholic subjects show several fold variation in
HMGB1+IR and over 10 fold variation in lifetime alcohol consumption. TLR2, TLR3, and
TLR4+IR also correlate with lifetime alcohol consumption (Table 4). The derived straight
line is shown (r = 0.82; p<0.001). In previous studies, we have shown that neuroimmune
activation persists for long periods once activated [8, 9]. The persistence of neuroimmune
activation likely contributes to progressive amplification of HMGB1/TLR induction with
repeated drinking that leads to cumulative increases [10] that result in correlations with
lifetime alcohol consumption.
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Figure 7. Ethanol induction of HMGB1 in rat brain slice culture
Brain slice culture was prepared and used after 2 weeks maturation in culture. Control or
ethanol (100mM) treated slices were collected following treatment and assessed for protein
or mRNA. (A) HMGB1 mRNA expression determined by real-time PCR as described in the
methods. Note ethanol increased HMGB1 mRNA about 4.5 fold (p<0.05). (B-top images)
Immunohistochemical double labeling of brain slice culture of control (left) and ethanol
(ETOH-100mM, right) treated slices for HMGB1 (red) and neuronal marker NeuN (green).
Note ethanol treatment of brain slices culture increases HMGB1+IR (red). Green is the
neuronal markers NeuN that combined with HMGB1 should appear yellow (red-green
merged) that represent HMGB1 expressing neurons (upper right image). (C – bottom
images) Immunohistochemistry of human hippocampus. A human moderate drinking
control (bottom-left) and alcoholic (bottom-right) brain section after immunohistochemistry
for HMGB1 (red) and neuronal marker NeuN (green). Note alcoholics show increased
HMGB1 (red) that is almost entirely expressed within NeuN (green) expressing neurons
such that all appear yellow. Arrows note HMGB1+IR in the cytoplasm consistent with
cellular release of nuclear HMGB1.
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Figure 8. Ethanol releases HMGB1 into media and activates IL-1β synthesis through TLR4
(A) Increased HMGB1 protein level in ethanol-treated HEC slice culture cell lysate and
medium. Left: HMGB1 released into culture medium, as assessed by ELISA, was increased
by approximately 3-fold in ethanol group (100 mM, 4 days). *p<0.001 compared with
control; n=4. This experiment was replicated 5 times and produced similar results. Right:
Representative Western blots of HMGB1 protein from HEC brain slice culture cell lysates
and medium. As depicted in right immunoblot, ethanol exposure increased HMGB1 protein
in both cell lysates and release into the culture medium. (B) Ethanol induction of IL-1β is
blocked by siRNA and neutralizing antibodies. Left: mRNA levels of the proinflammatory
cytokine IL-1β, relative to negative siRNA-treated controls. Ethanol induction of IL-1β was
blocked by siRNAs that knockdown either TLR4 or HMGB1 (*p<0.001 compared with
control, n=4). Shown on the right are mean ± SEM of proinflammatory cytokine IL-1β
mRNA level, relative to control that was treated with control antibody chicken IgY (10 μg/
ml) for HMGB1 neutralization (IBL, Germany). Ethanol induction of IL-1β mRNA is
blocked by HMGB1 neutralizing antibody (*p<0.0001 compared to Control; # p<0.0001
compared with EtOH).
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Figure 9. HMGB1+IR cells in OFC correlate with TLR2, TLR3 and TLR4+IR cells
Shown are individual subjects HMGB1+IR cells vs. TLR2, TLR3 or TLR4+IR cells. Across
subjects, HMGB1 correlated with TLR expression (r = 0.85; p<0.0001). Note that
HMGB1+IR varies several fold across subjects. Each subject’s TLR levels (e.g., TLR2,
TLR3, and TLR4 arrange in vertical points over each subject’s HMGB1 level. Although all
correlate with HMGB1, the TLRs showing the greatest induction varies across subjects. For
example, on the right are 3 subjects with the highest HMGB1 expression (alcoholics), two
showing TLR3>TLR4≥TLR2 and one with TLR4>TLR3>TLR2. Thus, among the TLRs
examined, all are increased without any apparent priority once activation has occurred. The
correlation of HMGB1 with TLR is consistent with neuroimmune loops of amplification
coordinating induction of all TLR. Activation of innate immune proinflammatory signaling
through multiple pathways is known to converge on signals leading to transcription of
multiple TLRs, proinflammatory cytokines, and their receptors that spread across cells
through paracrine and autocrine activation of proinflammatory signaling. The parallel
induction of TLR is a well-known mechanism of amplification of innate immune signals.
Our discovery of primarily neuronal localization of these signaling molecules suggest that
neuroimmune signaling amplification of multiple TLRs also occurs among neurons in brain
and is not unique to monocytes or microglia.
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Figure 10. Schematic of ethanol-induced release of HMGB1 and activation of TLR4 on neurons
and microglia IL-1β creating positive loops of amplification of innate immune cascades
Ethanol (alcohol) is shown releasing HMGB1 from the neuronal nucleus that stimulates
TLR4 on glia and neurons. Microglia contribute to the initiation of neuroimmune cascades
[59], and under basal conditions, are the only brain cells that express TLR4 in mice [37, 39].
TLR4 are critical for HMGB1 activation of innate immune cells [38], although the effect on
neurons is poorly understood. Ethanol activation of innate immune gene induction is
blocked by minocycline, an inhibitor of microglial activation [15], inhibitors of NF-κB [10],
inhibitors of IL-1β [14], naltrexone [15], and in microglial culture for transgenic mice
lacking TLR4 [40], as well as in ethanol-treated mouse brain of transgenic mice lacking
TLR4 [16]. We found HMGB1 is expressed primarily in neurons, consistent with studies
finding that neuronal hyperexcitability releases HMGB1 [46]. HMGB1/TLR4 activation
releases IL-1β, which activates its own receptors linked to proinflammatory transcription
cascades as well as releasing additional HMGB1 contributing to positive loops of
amplification of innate immune gene induction. In previous studies, we found ethanol-
induced NF-κB transcription of IL-1β, TNFα, MCP1, and IL-6 as well as oxidases,
proteases, and other innate immune genes [11]. Illustrated are our findings reported here that
ethanol releases HMGB1, and neutralizing antibody to HMGB1 and siRNA knockdown of
HMGB1 block ethanol induction of IL-1β. Also, TLR4 siRNA knockdown blocked ethanol
induction of IL-1β. This schematic illustrates ethanol initiation of positive loops of
activation between neurons and microglia. Astrocytes are activated as well and contribute to
altered neurotransmission although not illustrated for simplicity. Neuroimmune activation
increases TLR expression, which is primarily neuronal. HMGB1 is an agonist at multiple
TLRs and other brain neuroimmune receptors such as the receptor for glycation signals
(RAGE) [60] and (MAC-1) [61]. We found that chronic ethanol and post-mortem human
alcoholic brain had increased levels of TLR2, TLR3, and TLR4 as well as HMGB1
consistent with chronic neuroimmune activation that includes astrocytes, microglia, and
neurons. Activation of microglia increases neuronal excitatory synaptic potentials [62] as
well as initiating glial glutamate release [63] and neuronal extrasynaptic NMDA 2B
receptors are sensitized by HMGB1/TLR4 increased phosphorylation [46]. Further,
cytokines are known to inhibit glial glutamate transporters [22]. These findings support the
schematic illustration of increased HMGB1/TLR signaling leading to hyper-excitability due
to increased glutamate from glia and sensitized neuronal glutamate receptors. These findings
support hypotheses linking alcohol dependence to a hyperglutamate state [64, 65].
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Mouse TLR2 5′-TGC TTT CCT GCT GAA GAT TT-3′
5′-TGT ACC GCA ACA GCT TCA GG-3′
Mouse TLR3 5′-TTG TCT TCT GCA CGA ACC TG-3′
5′-GGC AAC GCA AGG ATT TTA TT-3′
Mouse TLR4 5′-ACC TGG CTG GTT TAC ACG TC-3′
5′-GTG CCA GAG ACA TTG CAG AA-3′
Mouse HMGB-1 5′-CCA TTG GTG ATG TTG CAA AG-3′
5′-CTT TTT CGC TGC ATC AGG TT-3′
Mouse β-actin 5′-GTA TGA CTC CAC TCA CGG CAA A-3′
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Table 4
Correlations of lifetime alcohol consumption and danger signals HMGB1, and TLR2, TLR3, and TLR4 in
post-mortem human OFC.
DANGER SIGNAL Lifetime Alcohol Consumption (kg) TLR2 TLR3 TLR4
















Lifetime alcohol consumption of moderate drinking controls and alcoholics is shown in Table 1. Correlations between lifetime alcohol
consumption with HMGB1, TLR2, TLR3, and TLR4 +IR cells within the orbital frontal cortex. Drinking history from family interviews and a
follow back technique was used to assess drinks per year and years drinking. Lifetime alcohol consumption (expressed in kilograms of 100%
alcohol) was calculated by multiplying the duration and the mean consumption rate (See methods for more details). Correlations were determined
using Pearson Correlation coefficients and 2 tailed significance. The correlation coefficient is above the p value in each applicable table cell.
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